Exploring factors influencing medication compliance | PPA - Dove Medical Press
Introduction Rheumatoid Arthritis (RA) is a chronic autoimmune disease that burdens patients' lives. 1 Outcomes of RA management have improved in the last two decades owing to early diagnosis, the introduction of highly effective therapies, and the adoption of a Treat To Target strategy. 2 Treatment options include conventional synthetic Disease-Modifying Anti-rheumatic Drugs (csDMARDs), target synthetic DMARDs (tsDMARDs), and biological DMARDs (bDMARDs). 3 Similar to other chronic diseases, treatment compliance is essential to achieve the desired therapeutic goal. 4,5 Methotrexate (MTX), the anchor drug in RA management, is usually started as a monotherapy orally or subcutaneously in moderate to severe RA patients. Its failure requires the addition of csDMARDs, bDMARDs, or tsDMARDs with a large variety of routes and frequencies of administration. However, this can negatively impact compliance with drugs administered daily compared to weekly or monthly injections. tsDMARDs ...